MedPath

An Idiographic Examination of Treatment Mechanisms in Emotion Regulation Therapy

Not Applicable
Active, not recruiting
Conditions
Worry
Anxiety
Distress, Emotional
Depression
Rumination
Self-Criticism
Interventions
Behavioral: Emotion Regulation Therapy via Telehealth
Registration Number
NCT05590741
Lead Sponsor
Teachers College, Columbia University
Brief Summary

This study is an open trial designed to examine individual changes that occur before, during, and after 12 sessions of Emotion Regulation Therapy (ERT) delivered via telehealth for individuals in New York State who are experiencing elevated worry, rumination, or self-criticism.

Detailed Description

The main questions this study aims to answer are to:

1. Examine temporal patterns of ERT-specific treatment mechanisms (attention regulation, metacognitive regulation, motivation regulation, and valued living), relationships between these mechanisms and negative self-referential processing (NSRP; i.e., rumination, worry, and self-criticism) severity over time, and changes in these mechanisms in response to specific intervention strategies/modules.

2. Investigate the effect of concordance and/or discordance between therapists and clients regarding skill acquisition, treatment goals, and case conceptualizations on treatment mechanisms as well as measures of treatment outcome and satisfaction.

3. Demonstrate the preliminary efficacy of a 12-session version of ERT in reducing symptoms of psychological distress (e.g., anxiety, depression, worry, rumination, self-criticism), changing ERT-specific treatment mechanisms (e.g., attention regulation), and improving quality of life and overall functioning.

Participants will:

1. Fill out an online pre-screening questionnaire and complete a structured clinical interview via Zoom Healthcare

2. Be enrolled as a patient at the Dean Hope Center for Educational and Psychological Services (DHCEPS), located at Teachers College

3. Attend 12 once-weekly telehealth ERT sessions

4. Complete 18 weekly questionnaires online via Qualtrics (two before starting treatment, 12 each week during treatment, and 4 after ending treatment).

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
24
Inclusion Criteria
  • Between the ages of 18 and 65
  • Fluent in English (and therefore able to provide consent)
  • Currently living in New York State
  • Access to at least one device with internet and video-conferencing capabilities
  • High self-reported worry, rumination, and/or self-criticism
  • Meet Diagnostic and Statistical Manual of Mental Disorders - Fifth Edition (DSM-5) criteria for at least one, current psychological disorder
Exclusion Criteria
  • Active suicidal ideation or intent
  • Substance dependence disorder, schizophrenia, bipolar-I disorder, or a primary DSM-5 diagnosis of borderline or narcissistic personality disorder
  • Currently in therapy or receiving any type of psychosocial treatment
  • Individuals taking psychotropic mediation that has not been stabilized for a period of at least 3 months
  • Current students at Teachers College, Columbia University

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
TreatmentEmotion Regulation Therapy via TelehealthAll participants will receive a 12-session version of Emotion Regulation Therapy delivered weekly via synchronous telehealth using videoconferencing software and an asynchronous Internet-based online platform to supplement the content covered in each session.
Primary Outcome Measures
NameTimeMethod
Weekly Assessment of Change in Valued Living/ActionWeekly from Baseline (2 weeks) through Treatment (12 weeks) and Follow-Up (4 weeks)

The Valuing Questionnaire (VQ) is a 10-item measure of the degree to which patients live by their values in daily life. It uses a 7-point Likert scale (0-6) to assess progress and obstructions to valued living. Higher scores on this measure indicate more valued living.

Weekly Assessment of Change in Clarity of Approach-Avoidance MotivationWeekly from Baseline (2 weeks) through Treatment (12 weeks) and Follow-Up (4 weeks)

The Mental Representation of Approach Avoidance Questionnaire (MRAAQ) is a 42-item self-report assessment designed to capture the mental representation of approach-avoidance motivation.

Weekly Assessment of Change in DecenteringWeekly from Baseline (2 weeks) through Treatment (12 weeks) and Follow-Up (4 weeks)

The decentering subscale of the Experiences Questionnaire (EQ-D) is an 11-item subscale assessing one's ability to distance themselves from their emotional experience, which is one metacognitive ER skill taught during ERT. Higher scores on this subscale indicate better ability to distancing oneself from one's emotional experience.

Weekly Assessment of Change in ReappraisalWeekly from Baseline (2 weeks) through Treatment (12 weeks) and Follow-Up (4 weeks)

The reappraisal subscale of the Emotion Regulation Questionnaire (ERQ) is a 6-item measure of the ability to regulate emotions, using the strategy of reappraisal. Higher scores on this subscale indicate a better ability to regulate emotions using the strategy of reappraisal.

Weekly Assessment of Change in Attentional ControlWeekly from Baseline (2 weeks) through Treatment (12 weeks) and Follow-Up (4 weeks)

The Attentional Control Scale (ACS) is a 21-item measure used to measure difficulties with concentration associated with problems regulating emotions. The focusing and shifting subscales of the ACS align with the two attention emotion regulation (ER) skills taught in ERT.

Secondary Outcome Measures
NameTimeMethod
Weekly Assessment of Change in WorryWeekly from Baseline (2 weeks) through Treatment (12 weeks) and Follow-Up (4 weeks)

The Penn State Worry Questionnaire - Past Week (PSWQ-PW) is an adapted version of the original PSWQ, contains 15 items (rated on a 0-6 scale), and assesses the extent to which worry has been excessive, uncontrollable, and pervasive in the past week. Higher scores on this measure indicate greater worry in the past week.

Weekly Assessment of Change in Depression SeverityWeekly from Baseline (2 weeks) through Treatment (12 weeks) and Follow-Up (4 weeks)

The Patient-Reported Outcomes Measurement Information System (PROMIS) Item Bank v. 1.0 - Emotional Distress - Depression - Short Form 8a will be administered to assess for depression severity. Higher scores on this measure indicate greater depression severity.

Weekly Assessment of Change in RuminationWeekly from Baseline (2 weeks) through Treatment (12 weeks) and Follow-Up (4 weeks)

The Rumination-Reflection Questionnaire (RRQ) is a 12-item measure that assesses past-focused rumination with specificity regarding the types of rumination that people may experience. Higher scores on this measure indicate greater rumination.

Weekly Assessment of Change in Self-CriticismWeekly from Baseline (2 weeks) through Treatment (12 weeks) and Follow-Up (4 weeks)

The self-judgment subscale of the Self-Compassion Scale (SCS) contains 5-items and assesses the tendency to self-criticize. Higher scores on this measure indicate greater self-criticism.

Weekly Assessment of Change in Anxiety SeverityWeekly from Baseline (2 weeks) through Treatment (12 weeks) and Follow-Up (4 weeks)

The Patient-Reported Outcomes Measurement Information System (PROMIS) Item Bank - Emotional Distress - Anxiety - Short Form 8a will be administered to assess for anxiety severity. Higher scores on this measure indicate greater anxiety severity.

Trial Locations

Locations (1)

Teachers College, Columbia University

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath